Terms: = Ovarian cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Prognosis
5 results:
1. PROM1, CXCL8, runx1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.
Dansonka-Mieszkowska A; Szafron LA; Kulesza M; Stachurska A; Leszczynski P; Tomczyk-Szatkowska A; Sobiczewski P; Parada J; Kulinczak M; Moes-Sosnowska J; Pienkowska-Grela B; Kupryjanczyk J; Chechlinska M; Szafron LM
PLoS One; 2022; 17(7):e0271539. PubMed ID: 35867729
[TBL] [Abstract] [Full Text] [Related]
2. LINC00861 inhibits the progression of cervical cancer cells by functioning as a ceRNA for miR‑513b‑5p and regulating the PTEN/AKT/mTOR signaling pathway.
Liu H; Zhang L; Ding X; Sui X
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179755
[TBL] [Abstract] [Full Text] [Related]
3. An integration analysis of mRNAs and miRNAs microarray data to identify key regulators for ovarian endometriosis based on competing endogenous RNAs.
Wang K; Sun Y; Wang Y; Liu L
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():468-475. PubMed ID: 32738676
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients.
Liu S; Ju X; Feng Z; Wen H; Xu J; Chen X; Wu X
Nucl Med Commun; 2018 Apr; 39(4):319-324. PubMed ID: 29533344
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of GPC6 and TMEM132D in Early Stage ovarian cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival.
Karapetsas A; Giannakakis A; Dangaj D; Lanitis E; Kynigopoulos S; Lambropoulou M; Tanyi JL; Galanis A; Kakolyris S; Trypsianis G; Coukos G; Sandaltzopoulos R
Biomed Res Int; 2015; 2015():712438. PubMed ID: 26448945
[TBL] [Abstract] [Full Text] [Related]
